Terri B. Sebree
2014
In 2014, Terri B. Sebree earned a total compensation of $622.9K as President at Zynerba Pharmaceuticals.
Compensation breakdown
| Salary | $87,692 |
|---|---|
| Stock Awards | $417,953 |
| Other | $117,264 |
| Total | $622,909 |
Sebree received $418K in stock awards, accounting for 67% of the total pay in 2014.
Sebree also received $87.7K in salary and $117.3K in other compensation.
Rankings
In 2014, Terri B. Sebree's compensation ranked 9,533rd out of 13,032 executives tracked by ExecPay. In other words, Sebree earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,533 out of 13,032 | 27th |
Division Manufacturing | 3,602 out of 4,966 | 28th |
Major group Chemicals And Allied Products | 1,229 out of 1,686 | 27th |
Industry group Drugs | 972 out of 1,365 | 29th |
Industry Pharmaceutical Preparations | 746 out of 1,043 | 29th |
Source: SEC filing on April 13, 2016.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2014.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019